← Back
$SKYE All transactions

Skye Bioscience, Inc.

A

$ Value

$0

Shares

75,000

Price

$0

Filed

Apr 2

Insider

Name

Smith Karen L.

Title

CIK

0001639637

Roles

Director

Transaction Details

Transaction Date

2026-03-31

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

75,000

Footnotes

The stock option vests in equal monthly installments over the one year period beginning March 31, 2026.

Filing Info

Accession No.

0001628280-26-023358

Form Type

4

Issuer CIK

0001516551

Smith Karen L.'s History

Date Ticker Type Value
2026-03-31 SKYE A $0
2025-06-12 CNTX A $0
2025-06-12 SGMO A $0
2025-06-12 SGMO A $0

Other Insiders at SKYE (90d)

Insider Bought Sold Last
DHILLON PUNIT
Chief Executive Officer
2026-03-31
Schwab Andrew J. 2026-03-31
Jenkins Annalisa 2026-03-31
Grayson Paul A. 2026-03-31
Twitty Christopher
Chief Scientific Officer
2026-03-31
Charych Deborah H. 2026-03-31
Diep Tuan Tu
Chief Operating Officer
2026-03-31